Stay updated on Pembrolizumab and Chemo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemo in Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Chemo in Bladder Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows Revision: v3.4.2 replacing Revision: v3.4.1, indicating a minor version update with no visible changes to study details, contacts, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no visible changes to core content or layout in the provided screenshots.SummaryDifference0.0%

- Check33 days agoChange DetectedThe updates are minor UI/metadata changes (show glossary, capitalization tweaks for QC and FEAR Act data) and a revision bump to v3.4.0, with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no substantive study content or workflow changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedUpdated the Study Locations: many new sites across the US, Canada, Europe, Australia, and other regions were added, while a large number of previously listed locations were removed.SummaryDifference4%

- Check97 days agoChange DetectedThe Publications section now notes that items are automatically filled from PubMed and may not be about the study. The revision number has been updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Chemo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemo in Bladder Cancer Clinical Trial page.